Lee Jae Hoon, Park Ki Hyuk
Division of Vascular and Endovascular Surgery, Department of Surgery, College of Medicine, Daegu Catholic University, Daegu, Korea.
Vasc Specialist Int. 2019 Mar;35(1):10-15. doi: 10.5758/vsi.2019.35.1.10.
There are several commercially approved stent grafts in Korea for the treatment of abdominal aortic aneurysms (AAAs). Each device has its advantages and disadvantages based on the patient's anatomy and the clinical situation. The Zenith device allows accurate and precise endograft placement, whereas the Endurant device has improved flexibility and trackability. We reviewed 5 cases in which a combination of the Zenith main body and the Endurant iliac limb was used.
From January 2010 to February 2015, 90 patients with AAA underwent endovascular aneurysm repair (EVAR) using the Zenith body at Daegu Catholic University Hospital. Among them, 5 patients who underwent EVAR with the Zenith body and Endurant iliac limb were included in this study.
The mean age of the patients was 74.20±3.35 years. All patients were men. The main reason for use of the Endurant iliac limb was aortoiliac angulation. Type III endoleak, stent migration, and stent kinking were not noted. Comparing 85 patients who received a Zenith endograft with 5 patients who received the hybrid endograft, there were no statistical differences in clinical characteristics, intraoperative details and post procedural complications. The mean admission duration was 19.00±13.60 days, and the mean follow-up duration was 1,018.11±925.34 days. In the hybrid endograft group, there was no mortality during the follow-up duration.
Although the material, radial force, diameter, and length of the overlap zone differ between the two devices, EVAR with the hybrid endograft is safe and effective.
韩国有几种经商业批准用于治疗腹主动脉瘤（AAA）的支架型人工血管。根据患者的解剖结构和临床情况，每种器械都有其优缺点。Zenith器械可实现准确、精确的腔内移植物置入，而Endurant器械的柔韧性和可跟踪性有所提高。我们回顾了5例使用Zenith主体和Endurant髂支的联合病例。
2010年1月至2015年2月，大邱天主教大学医院90例AAA患者接受了使用Zenith主体的血管内动脉瘤修复术（EVAR）。其中，5例接受了Zenith主体和Endurant髂支的EVAR患者被纳入本研究。
患者的平均年龄为74.20±3.35岁。所有患者均为男性。使用Endurant髂支的主要原因是主髂动脉成角。未发现III型内漏、支架移位和支架扭结。将85例接受Zenith腔内移植物的患者与5例接受混合腔内移植物的患者进行比较，临床特征、术中细节和术后并发症方面无统计学差异。平均住院时间为19.00±13.60天，平均随访时间为1018.11±925.34天。在混合腔内移植物组中，随访期间无死亡病例。
尽管两种器械重叠区的材料、径向力、直径和长度不同，但使用混合腔内移植物的EVAR是安全有效的。
